Mahavir Jayanti 2025: The auspicious festival of Mahavir Jayanti is being celebrated this year on Thursday, April 10. The festival celebrated with vigour and enthusiasm by Jains across the world ...

Mahavir Jayanti celebrates the birth of Lord Mahavir, the 24th Tirthankara of Jainism, on April 10, 2025. The festival honors his teachings of non-violence (Ahimsa), truth (Satya), compassion, and ...

Key suits were filed by third party mRNA and lipid pioneers that, while not having any mRNA-based products on the market themselves, leveraged their patent portfolios claiming a share of the ...

The United States led the world in developing the technology that beat the COVID-19 pandemic. Action from lawmakers may leave that legacy—and a $70 billion market—behind.

In this article, we are going to take a look at where Moderna, Inc. (NASDAQ:MRNA) stands against other best long term growth stocks to buy according to billionaires. As per Barclays, the US ...

The surprise delay is casting new uncertainty on the fate of another vaccine awaiting FDA action: Moderna’s next-generation Covid-19 shot, called mRNA-1283, which is set for a decision by May 31.

"The days of the dick pic are gone. I can't tell you how many dick GIFs I'm getting." The next day, I launched an investigation into whether or not people are *actually* sending "dick GIFs".

The partnership’s main focus is on developing the nasally delivered mRNA vaccine targeting influenza. Credit: mi_viri/Shutterstock. Ethris has partnered with contract development and manufacturing ...

Room-temperature stability aims to address significant supply chain challenges associated with some mRNA vaccines, including the dependence on ultra-low-temperature storage and complex delivery ...

Ethris and Lonza agreed to collaborate on the development of room-temperature stable, spray-dried formulations of mRNA-based vaccine candidates, designed for mucosal delivery to combat respiratory ...

NEW YORK – The US Food and Drug Administration has cleared CureVac to begin a Phase I trial of its mRNA-based precision immunotherapy CVHNLC in patients with squamous non-small cell lung cancer, the ...

This is known as a mixed vaccine series. The National Advisory Committee on Immunization (NACI) recommends an mRNA vaccine (Pfizer-BioNTech Comirnaty ® or Moderna Spikevax ®) should be offered for ...